Bold Expansion Will Help Mayo Clinic Increase Patient Access to Health Care in Arizona and Florida
Arizona. Bold. Forward.
Mayo Clinic is growing to increase access for more patients by doubling the size of the Phoenix campus, expanding locations around the globe and leveraging digital technology to connect even more people to Mayo experts.
A key component of Mayo Clinic’s path to 2030, Arizona. Bold. Forward. will increase capacity, accelerate new platforms for innovation, and provide more opportunities for research and education. With a focus on core services such as surgery, cancer, neurosciences, cardiovascular diseases, regenerative and individualized medicine, and transplantation, Mayo Clinic in Arizona will be poised for the future of medicine.
Through this expansion, Mayo Clinic will have a proof of concept of what works best for the future of all Mayo Clinic’s sites. This next-generation space will be where Mayo Clinic applies what has been learned and transforms that knowledge into what patients will need over the next 10 years and beyond.
Mayo Clinic’s expansion in Florida continues, delivering new possibilities for patients now and even more reasons for optimism in the years ahead.
In September 2019, Mayo Clinic announced approval from the Food and Drug Administration to offer sophisticated imaging tests in Florida that use radiopharmaceuticals. Radiopharmaceuticals are radioactive compounds that are tuned to specific features of diseases. For example, prostate cancer cells readily absorb carbon c-11 choline, which is a radiopharmaceutical that Mayo Clinic invented. That interaction makes it possible to use PET imaging to detect recurrent prostate cancer much earlier and with greater precision compared with conventional imaging.
The radiopharmaceuticals are produced in the Robert and Monica Jacoby Building, which was completed last year. From there, they are delivered to a new imaging center that is part of a recently completed addition to the Mayo Building in Florida.
These additions will improve care across several specialties, but they are also part of an evolution for cancer care in Florida. Mayo Clinic recently announced plans to build a $233 million integrated oncology facility that will link to the Mangurian Building and offer proton beam therapy and other advanced radiation oncology treatments. Housing these services close together will best serve patients with cancer and help to further integrate cancer care. The building is scheduled to open in 2023.
“We’re on an exciting path to grow, innovate and positively impact more lives,” says Kent R. Thielen, M.D., CEO of Mayo Clinic in Florida. “We’re tremendously grateful for the support of Bob and Monica Jacoby and many other benefactors whose gifts are helping us make a bold move forward here in the Southeast.”